
Manocit 35mg Tablet MR
Marketer
Cmg Biotech Pvt Ltd
Salt Composition
Trimetazidine (35mg)
Overview Manocit 35mg Tablet MR
Angigen 35mg Extended-Release Tablets are prescribed for the management of angina pectoris, a type of chest pain stemming from heart conditions. This medication acts to prevent future angina episodes but is ineffective in treating an ongoing attack. It can be administered independently or concurrently with other medications, as determined by your physician. Consistent daily use, as directed by your doctor, is crucial. Take Angigen 35mg ER tablets with or without food, maintaining a regular schedule. Dosage frequency may be adjusted based on your response to treatment. Continuous use, even during symptom-free periods, is vital for optimal preventative benefits. Discontinuing the medication may lead to a recurrence of angina. Complementing this treatment with lifestyle modifications – such as smoking cessation, moderate alcohol consumption, a balanced diet, regular physical activity, and stress management – can significantly enhance cardiovascular health. Potential side effects include lightheadedness, headache, stomach upset, diarrhea, dyspepsia, nausea, vomiting, skin rash, itching, urticaria, and fatigue. Report any persistent or bothersome side effects to your physician. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, pregnancy, breastfeeding, and all other medications you are currently using, as Angigen 35mg ER Tablets may not be appropriate for all individuals.
Uses of Manocit 35mg Tablet MR
Managing chest pain associated with angina pectoris
Major Benefits of Manocit 35mg Tablet MR:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Manocit 35mg Modified-Release Tablet should be administered with a meal.
Common Side effects of Manocit 35mg Tablet MR:
- Dizziness
- Headache
- Nausea
- Vomiting
- Weakness
- Rash
- Abdominal pain
- Indigestion
- Itching
- Diarrhea
- Hives
How to use Manocit 35mg Tablet MR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Manocit 35mg Tablet MR with a meal.
How Manocit 35mg Tablet MR works:
Manocit 35mg Modified-Release tablets treat angina by altering cardiac metabolism. This medication reduces the heart's oxygen demand through a metabolic shift from fatty acids to glucose, thus improving cardiac efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Manocit 35mg modified-release tablets and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Manocit 35mg MR tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Manocit 35mg Tablet MR use while breastfeeding is absent. Seek medical advice.
DrivingUNSAFE
Taking a Manocit 35mg Modified-Release tablet might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Exercise caution when administering Manocit 35mg MR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Manocit 35mg MR tablets are contraindicated in patients exhibiting severe kidney disease.
LiverCONSULT YOUR DOCTOR
Data regarding the use of Manocit 35mg Modified-Release tablets in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Manocit 35mg Tablet MR :
Should you forget a Manocit 35mg Tablet MR dose, take it immediately if you remember. However, near your next scheduled dose, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Manocit 35mg Tablet MR
| Label | Value |
|---|---|
| Chemical Type | Amphetamines |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Fatty acid modifier and sodium channel inhibitor |
